-
1
-
-
0001936994
-
Sedative-hypnotic drugs
-
Katzung BG, ed. Norwalk, CT: Appleton and Lange
-
Trevor AJ, Way WL. Sedative-hypnotic drugs. In: Katzung BG, ed. Basic and clinical pharmacology, 6th ed. Norwalk, CT: Appleton and Lange, 1995:333-47.
-
(1995)
Basic and Clinical Pharmacology, 6th Ed.
, pp. 333-347
-
-
Trevor, A.J.1
Way, W.L.2
-
2
-
-
0000965479
-
Hypnotics and sedatives; ethanol
-
Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds. New York: McGraw-Hill
-
Hobbs WR, Rall TW, Verdoom TA. Hypnotics and sedatives; ethanol. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds. Goodman & Gilman's The pharmacological basis of therapeutics, 9th ed. New York: McGraw-Hill, 1996:361-96.
-
(1996)
Goodman & Gilman's the Pharmacological Basis of Therapeutics, 9th Ed.
, pp. 361-396
-
-
Hobbs, W.R.1
Rall, T.W.2
Verdoom, T.A.3
-
3
-
-
0027971606
-
Benzodiazepine screening using EMIT II® and TDx®: Urine hydrolysis pretreatment required
-
Meatherall R. Benzodiazepine screening using EMIT II® and TDx®: urine hydrolysis pretreatment required. J Anal Toxicol 1994;18:385-90.
-
(1994)
J Anal Toxicol
, vol.18
, pp. 385-390
-
-
Meatherall, R.1
-
4
-
-
0028278659
-
Detecting benzodiazepines: Immunoassays compared with negative chemical ionization gas chromatography/mass spectrometry
-
Fitzgerald RL, Rexin DA, Herold DA. Detecting benzodiazepines: immunoassays compared with negative chemical ionization gas chromatography/mass spectrometry. Clin Chem 1994;40:373-80.
-
(1994)
Clin Chem
, vol.40
, pp. 373-380
-
-
Fitzgerald, R.L.1
Rexin, D.A.2
Herold, D.A.3
-
5
-
-
0026525333
-
Detection of benzodiazepine intake in therapeutic doses by immunoanalysis of urine: Two techniques evaluated and modified for improved performance
-
Beck O, Lafolie P, Hjemdahl P, Borg S, Odelius G, Wirbing P. Detection of benzodiazepine intake in therapeutic doses by immunoanalysis of urine: two techniques evaluated and modified for improved performance. Clin Chem 1992;38:271-5.
-
(1992)
Clin Chem
, vol.38
, pp. 271-275
-
-
Beck, O.1
Lafolie, P.2
Hjemdahl, P.3
Borg, S.4
Odelius, G.5
Wirbing, P.6
-
6
-
-
0028940922
-
Interference of oxaprozin with benzodiazepines via enzyme immunoassay technique
-
Matuch-Hite T, Jones P, Moriarity J. Interference of oxaprozin with benzodiazepines via enzyme immunoassay technique [Letter]. J Anal Toxicol 1995;19:130.
-
(1995)
J Anal Toxicol
, vol.19
, pp. 130
-
-
Matuch-Hite, T.1
Jones, P.2
Moriarity, J.3
-
7
-
-
0029004334
-
False-positive benzodiazepine urine test due to oxaprozin
-
Pulini M. False-positive benzodiazepine urine test due to oxaprozin. JAMA 1995;273:1905-6.
-
(1995)
JAMA
, vol.273
, pp. 1905-1906
-
-
Pulini, M.1
-
8
-
-
0028859260
-
False-positive immunoassay results for urine benzodiazepine in patients receiving oxaprozin (Daypro™) [Tech Brief]
-
Camara PD, Audette L, Velletri K, Breitenbecher P, Rosner M, Griffiths WC. False-positive immunoassay results for urine benzodiazepine in patients receiving oxaprozin (Daypro™) [Tech Brief]. Clin Chem 1995;41:115-6.
-
(1995)
Clin Chem
, vol.41
, pp. 115-116
-
-
Camara, P.D.1
Audette, L.2
Velletri, K.3
Breitenbecher, P.4
Rosner, M.5
Griffiths, W.C.6
-
9
-
-
0344418387
-
High sensitivity CEDIA® DAU benzodiazepine assay utilizing β-glucuronidase
-
Bellet NF, Scholz HA, Opel ML, Rytter H, Galloway FR, Khanna P. High sensitivity CEDIA® DAU benzodiazepine assay utilizing β-glucuronidase. J Anal Toxicol 1997;21:90-1.
-
(1997)
J Anal Toxicol
, vol.21
, pp. 90-91
-
-
Bellet, N.F.1
Scholz, H.A.2
Opel, M.L.3
Rytter, H.4
Galloway, F.R.5
Khanna, P.6
|